The public Empalab site presents an organisational model for supporting cosmetic care during and after treatment. Instead of a universal “allowed or prohibited” list, the interface offers three routes: a lower-trauma option under a protocol, discussion with a clinician, or temporary postponement of a procedure. The prototype structure includes a safety passport, procedure review, a personal care plan, the Emma digital navigator, transfer of a question to a coordinator and post-procedure monitoring. The page labels the current stage as a prototype being developed with clinical experts. Its public interface models 24 protocols in an initial knowledge base, three routing levels and 30 days of monitoring, but these figures describe service architecture, not published clinical results. The practical aim is to help a person structure a question and recognise when clinician review is needed. Empalab does not replace the treating clinician and is not an emergency service; individual medical decisions remain with a clinician. Route safety, usability and impact on real outcomes require independent validation.
Project review
Empalab: three routes for discussing care during treatment
The public Empalab site presents an organisational model for supporting cosmetic care during and after treatment. Instead of a universal “allowed or prohibited” list, the interface offers three routes: a lower-trauma option under a protocol, discussion with a clinician, or temporary postponement of a procedure. The prototype structure includes a safety passport, procedure review, a personal care plan, the Emma digital navigator, transfer of a question to a coordinator and post-procedure monitoring. The page labels the current stage as a prototype being developed with clinical experts. Its public interface models 24 protocols in an initial knowledge base, three routing levels and 30 days of monitoring, but these figures describe service architecture, not published clinical results. The practical aim is to help a person structure a question and recognise when clinician review is needed. Empalab does not replace the treating clinician and is not an emergency service; individual medical decisions remain with a clinician. Route safety, usability and impact on real outcomes require independent validation.